Inhaled Beclomethasone to Prevent Chronic Lung Disease

Frantz, Ivan D.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01HL049803-04
• Application #: 2028862
• Study Section: Clinical Trials Review Committee (CLTR)
• Project Start: 1993-06-01
• Project End: 1998-09-29
• Budget Start: 1996-09-30
• Budget End: 1997-09-29
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: Tufts University
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02111

Publications

Gupta, G K; Cole, C H; Abbasi, S et al. (2000) Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. Pediatr Pulmonol 30:275-81

Arias-Camison, J M; Lau, J; Cole, C H et al. (1999) Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatr Pulmonol 28:167-74

Cole, C H; Shah, B; Abbasi, S et al. (1999) Adrenal function in premature infants during inhaled beclomethasone therapy. J Pediatr 135:65-70

Cole, C H; Colton, T; Shah, B L et al. (1999) Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med 340:1005-10